Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing–Remitting Multiple Sclerosis.
Saved in:
| Title: | Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing–Remitting Multiple Sclerosis. |
|---|---|
| Authors: | Costa-Frossard, Lucienne1 (AUTHOR), Brieva, Luis2 (AUTHOR), García-Estévez, Daniel Apolinar3 (AUTHOR), Martín-Martínez, Jesús Manuel4 (AUTHOR), Álvarez-Bravo, Gary5 (AUTHOR), Blasco-Quílez, María Rosario6 (AUTHOR), Meca-Lallana, José E.7 (AUTHOR), Calles-Hernández, María Carmen8 (AUTHOR), Ramo Tello, Cristina9 (AUTHOR), Muñoz-Fernández, Carmen10 (AUTHOR), Barbero, David Enrique11 (AUTHOR), López-Muñoz, Pablo12 (AUTHOR), Prieto González, José María13 (AUTHOR), Candeliere-Merlicco, Antonio14 (AUTHOR), Carmona, Olga15 (AUTHOR), Riancho, Javier16,17 (AUTHOR), Sola-Valls, Nuria17,18 (AUTHOR), Carcelén-Gadea, María18,19 (AUTHOR), Borrega, Laura19,20 (AUTHOR), Gascón-Giménez, Francisco20,21 (AUTHOR) |
| Source: | International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 11, p4933. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16616596 |
|---|---|
| DOI: | 10.3390/ijms27114933 |
